Anti-EGFR immunoliposomes for cabazitaxel delivery: From formulation development to in vivo evaluation in prostate cancer xenograft model-Reference-Cited by-同舟云学术

Anti-EGFR immunoliposomes for cabazitaxel delivery: From formulation development to in vivo evaluation in prostate cancer xenograft model

Published:2024-08 Issue: Volume:661 Page:124439
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Carolina Cruz de Sousa Ana,da Silva Santos Elias,da Silva Moreira Thais,Gabriela Araújo Mendes Maria,Rodrigues Arruda Bruno,de Jesus Guimarães Celina,de Brito Vieira Neto José,Santiago de Oliveira Yara,Pedro Ayala Alejandro,Rodrigues da Costa Mac Dionys,Lima Sampaio Tiago,Paula Negreiros Nunes Alves Ana,Pessoa Cláudia,Petrilli Raquel,Eloy Josimar O.

Publisher

Elsevier BV

Reference85 articles.

1. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: Application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study;Abdelbary;Int. J. Pharm.,2015

2. Efficacy and toxicity outcomes of elderly castrate-resistant prostate cancer patients treated with docetaxel—A pooled analysis of 3 randomized studies;Abdel-Rahman;Urologic Oncol.: Semin. Orig. Investigat.,2020

3. Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET;Aerts;J. Nucl. Med.,2009

4. Cabazitaxel for the treatment of castration-resistant prostate cancer;Agarwal;Future Oncol.,2011

5. Aires Fernandes, M., O. Eloy, J., Tavares Luiz, M., Ramos Junior, S. L., Borges, J. C., Rodríguez de la Fuente, L., Ortega-de San Luis, C., Maldonado Marchetti, J., Santos-Martinez, M. J., Chorilli, M., 2021. Transferrin-functionalized liposomes for docetaxel delivery to prostate cancer cells. Colloids Surfaces A: Physicochem. Eng. Aspects, 611, 125806. Doi: 10.1016/j.colsurfa.2020.125806.